
浏览全部资源
扫码关注微信
1.河北省儿童医院,石家庄 050031
2.河北省中医院,石家庄 050013
3.河北医科大学 第一医院,石家庄 050030
4.河北工程大学 附属医院,河北 邯郸 056002
安娜,硕士,主管药师,从事临床药学服务工作,E-mail:jiangxillxb01@163.com
梁玉丽,硕士,副主任医师,从事儿童血液白血病的临床诊疗,E-mail:hjhttyh@163.com
收稿日期:2021-01-04,
网络出版日期:2021-02-03,
纸质出版日期:2021-10-05
移动端阅览
安娜,张古英,赵宜乐等.加味生脉饮辅助化疗对气血两虚证急性淋巴细胞白血病患儿的影响[J].中国实验方剂学杂志,2021,27(19):126-131.
AN Na,ZHANG Gu-ying,ZHAO Yi-le,et al.Effect of Modified Shengmaiyin on Children with Acute Lymphocyte Leukemia of Deficiency of Both Qi and Blood[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(19):126-131.
安娜,张古英,赵宜乐等.加味生脉饮辅助化疗对气血两虚证急性淋巴细胞白血病患儿的影响[J].中国实验方剂学杂志,2021,27(19):126-131. DOI: 10.13422/j.cnki.syfjx.20210631.
AN Na,ZHANG Gu-ying,ZHAO Yi-le,et al.Effect of Modified Shengmaiyin on Children with Acute Lymphocyte Leukemia of Deficiency of Both Qi and Blood[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(19):126-131. DOI: 10.13422/j.cnki.syfjx.20210631.
目的
2
观察加味生脉饮辅助化疗对气血两虚证急性淋巴细胞白血病(ALL)患儿营养情况和免疫功能的调节效果。
方法
2
将100例ALL化疗患儿按随机数字表法分为观察组和对照组各50例。两组患儿均给予长春新碱(泼尼松)+柔红霉素+左旋门冬酰胺酶(VDLD)方案进行诱导缓解治疗和环磷酰胺+阿糖胞苷+6-巯基嘌呤(CAM)方案进行早期强化治疗。对照组口服生脉饮,10 mL/次,3次/d。观察组口服加味生脉饮,1剂/d。两组疗程均为3个月。进行治疗前后微型营养评定(MNA),并检测治疗前后血清总蛋白(TB),白蛋白(ALB),前白蛋白(PAB),T细胞CD4
+
,CD8
+
,免疫球蛋白G(IgG),免疫球蛋白M(IgM),免疫球蛋白A(IgA)水平,计算CD4
+
/CD8
+
;进行治疗前后中医证候评分,Piper疲乏修订量表(PFS-R)和儿童生活质量普适性核心量表(PedsQL)评分;评价治疗前后白细胞(WBC),红细胞(RBC),血红蛋白(Hb)和血小板(PLT)变化。
结果
2
治疗后观察组营养状况高于对照组(
Z
=2.018,
P
<
0.05);观察组疲乏程度低于对照组(
Z
=2.029,
P
<
0.05);观察组MNA评分高于对照组(
P
<
0.01),PFS-R和气血两虚证评分均低于对照组(
P
<
0.01);观察组TB,ALB,PAB,CD4
+
水平和CD4
+
/CD8
+
均高于对照组(
P
<
0.01),CD8
+
低于对照组(
P
<
0.01);观察组IgM和IgA水平均高于对照组(
P
<
0.01);观察组RBC,Hb和PLT水平均高于对照组(
P
<
0.01)。
结论
2
加味生脉饮内服辅助用于ALL化疗患儿,可提高营养状况,改善免疫功能,促进免疫平衡,减轻临床症状,促进造血系统的恢复,提高生活质量。
Objective
2
To observe the regulatory effect of modified Shengmaiyin adjuvant chemotherapy on the nutritional status and immune function of children with acute lymphocyte (ALL).
Method
2
One hundred children with ALL chemotherapy were randomly divided into observation group and control group. Both groups were given VDLD regimen as the induction therapy and CAM regimen as the early therapy. Control group was given Shengmaiyin orally, 10 mL/time, 3 times/day. Observation group was given modified Shengmaiyin orally, 1 does/day. The course of treatment for both groups was 3 months. Micro-nutrition assessment (MNA) was carried out before and after treatment, and serum total protein (TB), albumin (ALB), prealbumin (PAB), T cell CD4
+
, CD8
+
, immunoglobulin G (IgG), IgM, IgA levels were detected before and after treatment. The ratio of CD4
+
/CD8
+
was calculated. The traditional Chinese medicine (TCM) syndrome before and after treatment and the piper fatigue scale (PFS-R) and universal core scale of children's quality of life (PedsQL) were scored. The changes of white blood cells (WBC), red blood cells (RBC), hemoglobin (Hb) and platelets (PLT) were evaluated before and after treatment.
Result
2
The nutritional status of the observation group was better than that of the control group after treatment (
Z
=2.018,
P
<
0.05). The observed fatigue was lighter than that of the control group (
Z
=2.029,
P
<
0.05). The MNA score of the observation group was higher than that of the control group (
P
<
0.01). The scores of PFS-R and deficiency of both Qi and blood were lower than those of the control group (
P
<
0.01). The CD4
+
levels and CD4
+
/CD8
+
levels of TB, ALB and PAB in the observation group were higher than those in the control group (
P
<
0.01), while the CD8
+
was lower than the control group (
P
<
0.01). The IgM and IgA levels in the observation group were higher than those in the control group (
P
<
0.01). The RBC, Hb and PLT levels of the observation group were higher than those of the control group (
P
<
0.01).
Conclusion
2
Modified Shengmaiyin can be used as adjuvant therapy for children with ALL chemotherapy by improving nutritional status, immune function and immune balance, reducing clinical symptoms, promoting the recovery of hematopoietic system and improving the quality of life.
蔡玉丽 , 邹尧 , 陈晓娟 , 等 . 982例儿童急性淋巴细胞白血病流行病学研究 [J]. 中国实验血液学杂志 , 2020 , 28 ( 2 ): 371 - 376 .
HUNGER S P , LOH M L , WHITLOCK J A , et al . Children's oncology group's 2013 blueprint for research:acute lymphoblastic leukemia [J]. Pediatr Blood Cancer , 2013 , 60 ( 6 ): 957 - 963 .
孙建明 , 董芳 . 儿童急性淋巴细胞白血病化疗后的不良反应 [J]. 昆明医科大学学报 , 2017 , 38 ( 10 ): 107 - 111 .
BURKE M J , RHEINGOLD S R . Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia [J]. Leuk Lymphoma , 2017 , 58 ( 3 ): 540 - 551 .
苏鑫 , 陈成顺 , 许亚梅 . 基于“毒损髓络”理论辨治急性白血病经验 [J]. 北京中医药 , 2020 , 39 ( 1 ): 44 - 47 .
杨茜 , 杜青容 , 吴娟丽 , 等 . 中药治疗白血病的研究进展 [J]. 新疆中医药 , 2019 , 37 ( 3 ): 86 - 89 .
黄衍强 . 白血病中医治验实录 [M]. 北京 : 人民军医出版社 , 2007 : 102 - 103 .
李焕 , 贾妮 . 论生脉散研究进展 [J]. 辽宁中医药大学学报 , 2020 , 22 ( 10 ): 190 - 193 .
中华医学会儿科学分会血液学组 , 《中华儿科杂志》编辑委员会 . 儿童急性淋巴细胞白血病诊疗建议(第四次修订) [J]. 中华儿科杂志 , 2014 , 52 ( 9 ): 641 - 644 .
郑筱茰 . 中药新药临床研究指导原则(试行) [M]. 北京 : 中国医药科技出版社 , 2002 : 378 - 380 .
乔德丽 , 吴红耀 , 凌莹 . 微型营养评定法在住院老年患者中的应用 [J]. 同济大学学报:医学版 , 2010 , 31 ( 2 ): 97 - 100 .
薛秀娟 , 许翠萍 , 杨雪莹 , 等 . 癌因性疲乏测评工具及评价指标的研究进展 [J]. 中华护理杂志 , 2012 , 47 ( 9 ): 859 - 861 .
卢奕云 , 田琪 , 郝元涛 , 等 . 儿童生存质量测定量表PedsQL4.0中文版的信度和效度分析 [J]. 中山大学学报:医学科学版 , 2008 , 29 ( 3 ): 328 - 331 .
BRINKSMA A , ROODBOL P F , SULKERS E , et al . Changes in nutritional status in childhood cancer patients:a prospective cohort study [J]. Clin Nutr , 2015 ; 34 ( 1 ): 66 - 73 .
黄璟 , 李静 , 何志旭 , 等 . 急性淋巴细胞白血病患儿在诱导缓解期的营养不良状况调查 [J]. 中国肿瘤临床 , 2018 , 45 ( 21 ): 1096 - 1099 .
DELUCHE E , GIRAULT S , JESUS P , et al . Assessment of the nutritional status of adult patients with acute myeloid leukemia during induction chemotherapy [J]. Nutrition , 2017 , 41 : 120 - 125 .
成娟 , 马海珍 , 张豪 . 急性白血病患者T,B淋巴细胞的检测与分析 [J]. 中国实验血液学杂志 , 2019 , 27 ( 2 ): 327 - 330 .
ALDOSS I , BARGOU R C , NAGOREN D , et al . Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia:bispecific T-cell engagers and chimeric antigen receptors [J]. Leukemia , 2017 , 31 ( 4 ): 777 - 787 .
陈楠楠 , 李海霞 , 黄世林 . 黄世林论治白血病经验 [J]. 中华中医药杂志 , 2017 , 32 ( 4 ): 1615 - 1617 .
祁永华 , 孙晖 , 张宁 . 中药辅助治疗化疗后骨髓抑制的实验研究进展 [J]. 中国医药导报 , 2020 , 17 ( 9 ): 21 - 24 .
0
浏览量
22
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621